Search nibr.novartis.com
Go

Novartis.com
Novartis worldwide
Print friendly
Contact us

Mark S. Boguski

Mark Boguski joined the Novartis Institutes for BioMedical Research (NIBR) in January 2005, both to found and to grow NIBR’s new integrated program in Genome and Proteome Sciences. In this position, he will oversee the critical interface of current genomic services (IK@N and Functional Genomics) with all Disease Areas and Platforms, as well as develop additional expertise necessary for the ongoing success of all NIBR research units.
 

Mark is well-known globally for his leadership and expertise in bioinformatics. Most recently he has served as the Director of the Allen Brain Atlas project, in addition to holding affiliate faculty appointments at the Fred Hutchinson Cancer Research Center and in the Department of Medicine/Genetics at the University of Washington. Prior to that, Mark was the senior vice president of Research and Development for Rosetta Inpharmatics, Inc. from 2000-2001.
 

Between 1989 and 2000, Mark was involved with the development of a number of high-impact, enabling information resources at the National Center for Biotechnology Information (NCBI). These include: dbEST; applications of UniGene for creation of the first large-scale maps of the human genome and the design of gene chips from expression profiling; and ArrayDB for management and analysis of expression data. He has also made significant research contributions to comparative genomics and pharmacogenomics.
 

Mark Boguski is the author or co-author of more than 100 scholarly books and articles and is the recipient of the Regents’ Award from the National Library of Medicine and the Director’s Award from the National Institutes of Health. He is a former editor of Genome Research, has served on the board of reviewing editors for Science magazine and is currently editor-in-chief of Genomics. He has been an organizer of the Cold Spring Harbor Symposium on DNA Mapping, Sequencing & Biology, a member of the scientific advisory board of the Merck Genome Research Institute, a member of the Genetics Advisory Group for the Wellcome Trust and an advisor to the Howard Hughes Medical Institute. In 2001 Mark was honored with election to the Institute of Medicine of the U.S. National Academy of Sciences and also as a fellow of the American College of Medical Informatics.
 

Mark received his M.D. and Ph.D. degrees from the Medical Scientist Training Program at the Washington University School of Medicine in St. Louis and pursued specialty training in pathology.